Crystalvue Medical Corporation (TPEX:6527)

Market Cap	1.84B -17.3%
Revenue (ttm)	949.05M +9.3%
Net Income	146.98M +15.6%
EPS	5.70 +15.2%
Shares Out	25.34M
PE Ratio	12.72
Forward PE	n/a
Dividend	2.25 (3.10%)
Ex-Dividend Date	Jul 24, 2025

Volume	15,305
Average Volume	16,424
Open	71.60
Previous Close	72.80
Day's Range	71.60 - 72.60
52-Week Range	68.60 - 93.00
Beta	0.89
RSI	38.28
Earnings Date	Mar 3, 2026

About Crystalvue Medical

Crystalvue Medical Corporation designs, produces, and sells medical devices worldwide. The company offers optical coherence tomography, retinal cameras, tonometers, lens edgers, and gastroenterology supplies, as well as ODM/OEM services for automated nucleic acid extraction instrument and PCR system. It also sells minimal invasive endoscopic instrument supplies. The company was founded in 2009 and is based in Taoyuan City, Taiwan.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2009
• Employees: 109
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6527

Financial Performance

In 2025, Crystalvue Medical's revenue was 949.05 million, an increase of 9.33% compared to the previous year's 868.03 million. Earnings were 146.98 million, an increase of 15.59%.